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• Hemorrhages are the leading cause of mortality in
battlefield trauma and the second leading cause of
death in civilian trauma.
• There is a lack in ability to care for non-compressible
hemorrhages.
• Electrospun nanofibers peanuts can be used to create
internal compression for junctional hemorrhaging.
• Electrospinning is method to produce nanofibers
by charging and ejecting a polymer solution
through a spinneret in a high-voltage electric field.
• Taylor cones involve the evaporation of solvent
leaving the solid form of the solute to be radial
spun into nanofibers causing the cone-shape.
• The drum is also negatively charge creating an
electric field that attracts the positively charged
nanofibers to adhere to the drum.
• These nanofibers then forms a nanofiber layered
sheet that has a multitude of applications.
• Initially we prepared a solution of 10%
polycaprolactone (PCL) with 1% Pluronic F-127 was
dissolved in 600 ml solution of dichloromethane
(DCM), dimethylformamide (DMF), and hexafluoro-2-
propanol (HFIP) in a ratio of 3.5:1:0.5.
• The solution was then electrospun into a matt with a
thickness of 1-3 mm.
• This matt was then cut into a 1.6 x 1.6 cm squares
while submerged in liquid nitrogen to avoid fusion of
the nanofiber layers from the pressure of cutting with
scissors.
• Nanofibers squares were then placed in 1M sodium
borohydride solutions whose reaction causes the
formation of hydrogen gas, which expands nanofibers
layers into 3D.
• Expanded squares where then soaked in 0.8% gelatin to
improve the peanuts mechanical properties.
• The gelatin coated in peanuts were then placed in a 3D
printed mold with 1.5 x 1.5 x 6 cm arrays. Then it
expands and dry under the freeze dryer to get desired
shape.
• After expansion, peanuts were then crosslinked with
glutaraldehyde vapor to improve elastic property.
• Then the peanuts were coated with thrombin (0.1%), a
blood clotting agent, to enhance the clotting efficiency
of nanofiber peanuts.
• The peanuts were then compressed into pellets using
water soluble polyvinylpyrrolidone thread.
• Then the pellets are placed into syringe for application
purposes.
• Hemostatic nanofiber peanuts could eventually be used in clinical application
in order to fill the gap existent in the lack of ability to apply internal
compression to junctional hemorrhages.
• The future of this application of these nanofiber peanuts could be to use these
as first aide for hemorrhages resulting in a drastic reduction in the mortality
rate of battlefield and civilian trauma.
Conclusion
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Figure 2. Confocal microscopy images
showing tubular network formation from
HUVECs seeded on PCL:gelatin:GelMA
(1:0.5:0.5) NMs without (A) and with (B)
conjugation of QK peptides in the simulated
medium for 3 and 7 days. The cells were
stained with CD31 in pink and
counterstained with DAPI in blue.
• Minimally invasive therapies can avoid surgical complexities therefore injectable
materials holds enormous potential in clinical applications.
• Nanofiber microspheres (NMs) have been explored as form of transport for various
biomolecules and cells for tissue repair and regenerative applications.
Results
• We prepared a large scale
production of expanded nanofiber
peanuts that is convertible to large-
scale production.
• A crosslinking chamber was made
that allowed for the glutaraldehyde
to be placed on the bottom and the
expanded peanuts to be placed on
mesh a few inches above. Then air
was circulated using to fans
connected by a tube keeping it a
closed system. This resulted in a
much more even crosslinking of
the peanuts and a faster rate of
linkage.
• The large-scale study designed
with pigs is expected to occur in
future studies.
• Here we are comparing blood
clotting efficiency to commercially
available XSTAT 30 as a control.
Chen, Shixuan et al. “Fabrication of injectable and superelastic nanofiber rectangle matrices ("peanuts") and their
potential applications in hemostasis.” Biomaterials vol. 179 (2018): 46-59. doi:10.1016/j.biomaterials.2018.06.031
• PCL/gelatin (1:1) nanofiber matts were made using
electrospinning.
• These matts were cut and frozen into a cube to be
cryocut in order to make nanofiber segments.
• The nanofibers segments are combined with gelatin, a
crosslinker, then homogenized using probe sonicator.
• The solution is then electrosprayed with and without
air into liquid nitrogen collector.
• The microspheres are then freeze-dried followed by
crosslinking with glutaraldehyde.
• Tether Peptides to the microspheres using different
techniques in order to regulate responses such as
osteogenesis and angiogenesis.
John JV, et al, Tethering peptides onto biomimetic and injectable nanofiber
microspheres to direct cellular response. Nanomedicine: 
NBM2019;22:102081, https://doi.org/10.1016/j.nano.2019.102081
• NMs generated with a 5% crosslink ratio can
maintain shape and mechanical stability.
• When using microspheres to promote growth of
human umbilical vein endothelial cells (HUVECs)
data should significant number of junction nodes and
vascular tubes.
• It has been demonstrated an approach for
fabrication of biomimetic and injectable
peptide-tethered NMs by combining
electrospinning, electrospraying, and
surface conjunction techniques.
• NMs can be used as injectable carriers
for cellular delivery through minimally
invasive procedure.
Figure 4. Hemostatic efficacy test in vivo.
(A) In vivo test procedure. (I) A pile of 0.5%
gelatin-coated nanofiber peanuts. (II)
Exposure of injury site (Grade V hepatic
dome laceration) 1 h after treatment with
nanofiber peanuts. Cotton lap pads have been
removed, showing 0.5% gelatin-coated PCL
nanofiber peanuts still packed into the injury
defect. (III) Close-up of injury site. Forceps is
beginning to extract the peanuts. (IV)
Nanofiber peanuts after removal from wound.
(B) H&E staining of the wound. Green dots
indicate the wound edge.
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Figure 2. Photographs illustrating the packing and
injection of nanofiber peanuts. (A) Expanded
nanofiber peanuts. (B) PVP nanofiber threads made
by rolling the fine strips. (C) Packed nanofiber
peanuts. (D) Packed nanofiber peanuts loaded in the
syringe. (E) Inject packed nanofiber peanuts into
water for different times
Figure 3. The cross-section structures of the Y-Z,
X-Z, and X-Y planes of PCL nanofiber matts
before and after expansion.
Figure 1. Scheme illustrating the fabrication of peptides-tethered NMs and their applications. (i) Cryocut
or homogenize electrospun nanofiber mats to generate nanofiber segments. (ii) Add crosslinker (e.g.,
gelatin) to the nanofiber segment solution and homogenize the solution. (iii) Electrospray the crosslinker-
containing nanofiber segment solution into liquid nitrogen. (iv) Freeze-drying the obtained microspheres.
(v) Crosslink the microspheres after freeze-drying. (vi) Tether peptides to the microspheres using different
surface conjugation techniques for directing cellular response such as osteogenesis and angiogenesis.
Figure 3. SEM images of NMs composed of PCL:gelatin






our purposes, it has
been found that
alternating needles
on the spinneret head
lessens the crossing
of Taylor cones. The
top left image shoes
the Taylor cone
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